Small-molecule A485 mobilizes white blood cells on demand

New study reveals a small molecule that can selectively mobilize white blood cells, offering potential treatments for diseases with abnormal leukocyte counts.

Lykos cuts team by 75%, vows to keep MDMA program despite FDA veto

Lykos will be culling 75% of its workforce as it continues to work on the MDMA therapy. Image credit: Getty Images / mathisworks Lykos Therapeutics

August 16, 2024

What’s behind the urge to scratch that itch? Harvard researchers have a theory

That itchy feeling isn’t just in your head, in some cases it might actually be all over you. And it may literally get on your

November 22, 2023

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

A recent study in BMC Medicine found that type 2 diabetes significantly increases the risk of various cancers, with the risk being even higher in

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.